Ophthalmology Doctors in Elmwood Park, IL Accepting Medicare
6 Ophthalmology doctors found. Showing 1 - 6
 Dr. Irene M Bakos, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7740 W North Ave, Elmwood Park, IL 60707 Phone: 708-450-0500 Fax: 708-450-1070 |
 Peter Panton, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7740 W North Ave, Elmwood Park, IL 60707 Phone: 708-452-7200 |
Manuel D Santiago, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 7638 W North Ave, Elmwood Park, IL 60707 Phone: 708-452-4257 Fax: 708-452-4283 |
Robert Panton, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7740 W North Ave, Elmwood Park, IL 60707 Phone: 708-452-7200 |
A. Gwendolyn Noble, M.D., PH.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7638 W North Ave, Elmwood Park, IL 60707 Phone: 708-452-4257 Fax: 708-452-4283 |
Dr. Michael Hennessey, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7638 W North Ave, Elmwood Park, IL 60707 Phone: 708-452-4257 Fax: 708-452-4283 |
News Archive
Blog posts respond to GHI office closure
In a joint message released by USAID Administrator Rajiv Shah, U.S. Global AIDS Coordinator Ambassador Eric Goosby, CDC Director Thomas Frieden, and Global Health Initiative (GHI) Executive Director Lois Quam last Tuesday, the Obama administration announced the closure of the GHI office, writing that the office's work is being "elevated" to the State Department's new Office of Global Health Diplomacy.
Some doctors refuse to purchase cervical cancer vaccine because of low reimbursements
Some physicians are refusing to purchase Merck's cervical cancer vaccine Gardasil or are restricting who receives it because they say insurance reimbursements for the vaccine are too low, the Washington Post reports.
Irregular sleep schedules linked to adverse metabolic health in midlife women
A new study suggests that frequent shifts in sleep timing may be related to adverse metabolic health among non-shift working, midlife women.
Nucala (mepolizumab) approved for treatment of asthma patients
The U.S. Food and Drug Administration today approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older. Nucala is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines.
› Verified 3 days ago
Family Medicine
Surgery
Ophthalmology
Internal Medicine
Obstetrics & Gynecology
Pediatrics
Psychiatry & Neurology